Translational medicine (TM) is often labeled as "Bench to Bed-side" since it involves the movement of research from laboratory to the clinical practice. TM is synonymous with "Molecular Medicine" or "Personalized Medicine" as all of them refer to the process of applying molecular insight to the clinical care of the patients. TM has a new paradigm and it differs from traditional drug discovery and development. As per the Journal of Translational Medicine, it is a bidirectional process, the first one goes from "bench to bed-side" where theories emerging from preclinical experiments are tested on disease-affected human subjects and then from "bed-side to bench," where information obtained from human experiments is used to refine the understanding of biological principles, heterogeneity of human disease, and polymorphism.
展开▼
